Cardiovascular disease in patients with chronic kidney disease

Por Wright, Julian, Hutchison, Alastair
Publicado em 2009

Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden

Por Hutchison, Alastair J., Laville, Maurice
Publicado em 2008

Use of magnesium as a drug in chronic kidney disease

Por Hutchison, Alastair J., Wilkie, Martin
Publicado no Clin Kidney J (2012)

Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate

Por Mohammed, Ismail A, Hutchison, Alastair J
Publicado em 2008

Enabling self-management: selecting patients for home dialysis?

Por Hutchison, Alastair J., Courthold, Jonathan J.
Publicado no NDT Plus (2011)

Update and critical appraisal of sevelamer in the management of chronic renal failure

Por Grinfeld, Jacob, Inaba, Akimichi, Hutchison, Alastair J
Publicado em 2010

A Study to Inform the Design of a National Multicentre Randomised Controlled Trial to Evaluate If Reducing Serum Phosphate to Normal Levels Improves Clinical Outcomes including Mor...

Por Bhargava, Ramya, Kalra, Philip A., Brenchley, Paul, Hurst, Helen, Hutchison, Alastair
Publicado no Int J Nephrol (2015)

Lanthanum carbonate: safety data after 10 years

Por Hutchison, Alastair J, Wilson, Rosamund J, Garafola, Svetlana, Copley, John Brian
Publicado no Nephrology (Carlton) (2016)

Incidence and consequence of acute kidney injury in unselected emergency admissions to a large acute UK hospital trust

Por Challiner, Rachael, Ritchie, James P, Fullwood, Catherine, Loughnan, Paul, Hutchison, Alastair J
Publicado em 2014

Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of d...

Por Hutchison Alastair J, Gill Maggie, Copley J Brian, Poole Lynne, Wilson Rosamund J
Publicado em 2013-02-01

Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of d...

Por Hutchison, Alastair J, Gill, Maggie, Copley, J Brian, Poole, Lynne, Wilson, Rosamund J
Publicado em 2013

Dissolution of extensive urolithiasis: extending the utility of rasburicase can avoid the need for surgical intervention and renal replacement therapy

Por Rezvani, Sean, Zelhof, Bachar, Hutchison, Alastair, Selby, Peter, Picton, Michael, Grey, Ben R.
Publicado no J Surg Case Rep (2016)

Long-Term Efficacy and Safety Profile of Lanthanum Carbonate: Results for up to 6 Years of Treatment

Por Hutchison, Alastair J., Barnett, M. Edwina, Krause, Rolfdieter, Kwan, Jonathan T.C., Siami, Ghodrat A.
Publicado em 2008

Iron-Magnesium Hydroxycarbonate (Fermagate): A Novel Non-Calcium-Containing Phosphate Binder for the Treatment of Hyperphosphatemia in Chronic Hemodialysis Patients

Por McIntyre, Christopher W., Pai, Pearl, Warwick, Graham, Wilkie, Martin, Toft, Alex J., Hutchison, Alastair J.
Publicado em 2009

Encapsulating peritoneal sclerosis following renal transplantation despite tamoxifen and immunosuppressive therapy

Por de Freitas, Declan, Augustine, Titus, Hurst, Helen, Taylor, Paul, Williams, Rosalind, Hutchison, Alastair, Brenchley, Paul E. C., Summers, Angela M.
Publicado no NDT Plus (2008)

Outcomes of Peritoneal Dialysis Patients and Switching to Hemodialysis: A Competing Risks Analysis

Por Pajek, Jernej, Hutchison, Alastair J., Bhutani, Shiv, Brenchley, Paul E.C., Hurst, Helen, Perme, Maja Pohar, Summers, Angela M., Vardhan, Anand
Publicado em 2014